Cetuximab preclinical antitumor activity (monotherapy and combination based) is not predicted by relative total or activated epidermal growth factor receptor tumor expression levels
Year: 2006
Type: article
Source: Molecular Cancer Therapeutics
Institution: Bristol-Myers Squibb (United States)
Language: English
Topic: HER2/EGFR in Cancer Research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Bristol-Myers Squibb
OpenAlex ID: W2051084702
